These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1244922)

  • 1. Evidence that Fitzgerald factor counteracts inhibition by kaolin or ellagic acid of the amidolytic properties of a plasma kallikrein.
    Ratnoff OD; Saito H
    Blood; 1976 Feb; 47(2):243-51. PubMed ID: 1244922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin.
    Ratnoff OD
    J Lab Clin Med; 1980 Aug; 96(2):267-77. PubMed ID: 7400662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fujiwara trait: the first case of kininogen deficiency in Japan.
    Oh-Ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Adv Exp Med Biol; 1979; 120B():93-9. PubMed ID: 517263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
    Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (factor XII): report of a case with observation on in vivo and in vitro leukocyte chemotaxis.
    Poon MC; Moore MR; Castleberry RP; Lurie A; Huang ST; Lehmeyer J
    Am J Hematol; 1982 May; 12(3):261-70. PubMed ID: 6919394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the activation of Hageman factor (factor XII) by beta 2-glycoprotein I.
    Henry ML; Everson B; Ratnoff OD
    J Lab Clin Med; 1988 May; 111(5):519-23. PubMed ID: 3361230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas.
    Saito H; Goldsmith G; Waldmann R
    Blood; 1976 Dec; 48(6):941-7. PubMed ID: 1000085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of high molecular weight kininogen for contact activation of rat blood coagulation, in vitro.
    Damas J; Bourdon V
    Arch Int Physiol Biochim; 1990 Mar; 98(1):67-73. PubMed ID: 1692696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments.
    Ratnoff OD
    Blood; 1981 Jan; 57(1):55-8. PubMed ID: 7448415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first cases of Fitzgerald factor deficiency in the Orient: three cases in one family.
    Hayashi H; Koya H; Kuroda M; Kitazima K; Kimura I; Katori M; Oh-ishi S
    Acta Haematol; 1980; 63(2):107-13. PubMed ID: 6768213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).
    Saito H; Ratnoff OD; Waldmann R; Abraham JP
    J Clin Invest; 1975 May; 55(5):1082-9. PubMed ID: 16695963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.